Advanced Micro Devices is a publicly traded company in the Technology sector. As a major technology firm, this company faces both opportunities and risks from Congressional action on AI regulation, data privacy legislation, semiconductor policy, and antitrust enforcement. HillSignal is tracking 7 active Congressional signals mentioning Advanced Micro Devices, including 7 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
HR8287 is a procedural bill requiring a one-year study on existing semiconductor export controls. It authorizes zero spending and changes no regulations. Neutral market impact with no direct effect on covered semiconductor companies.
→ no change to AMD's existing export license status or China-exposed revenue
HR8488 is an early-stage procedural bill requiring AI data center developers to disclose location, power, water, and supply chain details before construction. It has no funding, no enforcement, and is referred to committee. The bill's direct market impact on NVDA ($200.59), AMD ($347.62), and SMCI ($27.11) is neutral — it adds regulatory friction but no near-term revenue change for any ticker analyzed.
→ Creates a 6-12 month pre-construction review period, slowing new data center deployment timelines and increasing regulatory compliance costs for developers.
The SCALE Act (HR8306) codifies existing AI chip export restrictions into a predictable annual review cycle. For $NVDA, $AMD, and $SMCI, this removes sudden ban risk but locks out China revenue growth. NVDA at $200.67 sits near its 52-week high of $216.83; the stock is down 6.6% from its April 28 close of $213.17. Market is pricing in limited near-term disruption from this early-stage bill.
→ Annual review system limits AMD's ability to grow China-accessible AI accelerator sales beyond current restricted levels
HR8283, the 'Deterring American AI Model Theft Act of 2026', is an early-stage bill expressing a sense of Congress regarding foreign extraction of closed-source AI model weights. It authorizes no appropriations, creates no compliance obligations for public companies, and remains in committee awaiting floor action. Near-zero market impact.
Stop Stealing our Chips Act (HR6322) establishes a whistleblower program for export control violations on advanced AI chips but allocates no new funding and imposes no new restrictions. Compliance costs increase marginally for affected chip exporters, with no immediate financial gains or losses for major semiconductor companies.
→ Increased compliance and legal risk monitoring costs to avoid whistleblower claims under expanded reporting incentives
The AI OVERWATCH Act (HR6875) proposes mandatory export licenses for advanced integrated circuits to China and other countries of concern, directly targeting AI-chip heavyweights NVDA, AMD, and INTC. The bill is in early legislative stages (referred to committee), but its regulatory signal has already been partially priced into the sector. Real market data shows NVDA at $208.27 near its 52-week high of $216.83; AMD at $333.98 up 64% in 30 days; INTC at $92.92 up 111% in 30 days—these recent rallies reflect broader AI optimism, not this bill, which remains a headwind if it advances.
→ AMD's MI300 series and future AI accelerators fall under ECCN 3A090; export licenses required for China-bound shipments will restrict revenue from this growth segment
HR6996, the Full AI Stack Export Promotion Act, reported out of House Foreign Affairs on a 37-7 vote, reduces regulatory barriers for U.S. AI chip, cloud, and infrastructure exports to allies. Real market data shows broad AI infrastructure momentum: AMD surging 72% in 30 days, Intel up 130% on broader restructuring, NVDA trading at $209 near its 52-week high. This bill structurally favors U.S. AI hardware and cloud providers by creating a formal export facilitation mechanism for allied nations. No explicit funding — it's a regulatory and policy shift, not an appropriations bill.
→ Expanded export market access for AMD's AI GPU portfolio, currently facing similar BIS export restrictions. Lower regulatory friction for selling to allied government and enterprise AI deployments looking for a second-source vendor.